Wells Fargo’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-199,400
| Closed | -$4.33M | – | 6159 |
|
|
2017
Q2 | $4.33M | Buy |
199,400
+30,793
| +18% | +$668K | ﹤0.01% | 2548 |
|
|
2017
Q1 | $2.37M | Buy |
168,607
+29,338
| +21% | +$412K | ﹤0.01% | 3025 |
|
|
2016
Q4 | $2.61M | Buy |
139,269
+27,270
| +24% | +$512K | ﹤0.01% | 2908 |
|
|
2016
Q3 | $1.85M | Buy |
111,999
+39,975
| +56% | +$660K | ﹤0.01% | 2992 |
|
|
2016
Q2 | $968K | Buy |
72,024
+18,794
| +35% | +$253K | ﹤0.01% | 3443 |
|
|
2016
Q1 | $814K | Buy |
53,230
+4,941
| +10% | +$75.6K | ﹤0.01% | 3473 |
|
|
2015
Q4 | $958K | Buy |
48,289
+32,485
| +206% | +$644K | ﹤0.01% | 3429 |
|
|
2015
Q3 | $275K | Sell |
15,804
-6,713
| -30% | -$117K | ﹤0.01% | 4153 |
|
|
2015
Q2 | $455K | Buy |
22,517
+5,013
| +29% | +$101K | ﹤0.01% | 4060 |
|
|
2015
Q1 | $308K | Buy |
17,504
+16,412
| +1,503% | +$289K | ﹤0.01% | 4105 |
|
|
2014
Q4 | $18K | Sell |
1,092
-57,294
| -98% | -$944K | ﹤0.01% | 5208 |
|
|
2014
Q3 | $1.29M | Buy |
58,386
+56,518
| +3,026% | +$1.25M | ﹤0.01% | 3275 |
|
|
2014
Q2 | $38K | Buy |
1,868
+1,628
| +678% | +$33.1K | ﹤0.01% | 4948 |
|
|
2014
Q1 | $4K | Buy |
240
+184
| +329% | +$3.07K | ﹤0.01% | 5417 |
|
|
2013
Q4 | $1K | Sell |
56
-33,099
| -100% | -$591K | ﹤0.01% | 5441 |
|
|
2013
Q3 | $427K | Buy |
33,155
+31,671
| +2,134% | +$408K | ﹤0.01% | 3809 |
|
|
2013
Q2 | $18K | Buy |
+1,484
| New | +$18K | ﹤0.01% | 4816 |
|